{
  "12796618-DS-17": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\n___, GNR bacteremia \n \nMajor Surgical or Invasive Procedure:\nRight percutaneous nephrostomy placement ___\n\n \nHistory of Present Illness:\nMr. ___ is an ___ year old M w/ PMH prostate cancer ___ years \nago s/p radical prostatectomy/lymph node resection complicated \nby LLE lymphedema, chronic urinary incontinence requiring condom \ncath now with indwelling foley, CAD s/p MI, mild dementia who \npresented to ___ with nausea, vomiting and was found to have \n___, right hydronephrosis and GNR bacteremia.\n\nPatient has a history of prostate cancer and he is s/p radical \nprostatectomy/lymph node resection complicated by RLE \nlymphedema; patient has a history of urinary retention requiring \ncondom catheters at baseline, even before bladder tumor \nresection on ___\n\nOf note, on ___ he patient underwent bladder tumor \nresection and was found to have urothelial cancer and prostate \ncancer ___ 8 on pathology.\n\nHe presented to ___ with N/V and was found to have Cr 4.6 \non ___ from prior Cr 1.3 one week prior. CT A/P and renal \nUS showed right sided hydronephrosis without calculus. Cr \nimproved from 4.6 to 2.7 with IVF. Urologist Dr. ___ \nperformed his resection surgery was consulted who stated that \nbased on operative findings, the cancer is quite extensive and \nit appears that not all of the cancer was resected. He did not \nthink that urology could access ureterovesical junction via \ncystoscopy so he recommended percutaneous nephrostomy tube at \nthis time. Plan was to do hormonal therapy for the cancer as an \noutpatient. A bone scan was done which was negative for mets.\nOn ___ the patient developed a fever of 100.4 and \nleukocytosis. UA was done and UCx was done which grew GNRs. \nBlood cultures were drawn which grew GNRs. He was started on IV \nZosyn.\n\nHe also developed sudden onset chest pain with T wave inversions \nin the inferior lateral leads on ___. Troponin was 0.52 which \nincreased to 0.55 and 0.59. Cardiology was consulted and he was \nstarted on aspirin, Lipitor, metoprolol, and heparin gtt. Repeat \nEKG was similar to prior with no dynamic changes.\n\nPatient was also noted to have delirium, has known baseline \ndementia. He was noted to sundown daily but confusion had \nresolved prior to transfer per discharge summary.\nPer nephrology notes at ___:\n\nOvernight, pt with chest pain and shortness of breath, evaluated \nby covering physician and found to have EKG changes and more \nelevated troponin. Pt given aspirin, nitroglycerin, metoprolol, \nstatin, and started on a heparin infusion. Pt seen by cardiology \nthis morning with recommendation for medical management pending \nclinical course, check echocardiogram and continue medications. \nUrinalysis yesterday with blood, protein, nitrite, and leukocyte \nesterase. Urine culture this morning with gram negative rods. \nBlood cultures from yesterday with gram negative rods this \nmorning. Pt started on Zosyn 2.25g q6h.\nPt seen by urology this morning with recommendation for right \npercutaneous nephrostomy tube placement. Pt is currently \nscheduled for transfer to ___ for further management.\n\nOn arrival to the floor, pt reports that he is chest pain free \nand feels cold. He denies shortness of breath. He denies lower \nextremity pain. \n \nPast Medical History:\nProstate cancer > ___ years ago s/p radical prostatectomy/lymph \nnode resection complicated by RLE lymphedema\nChronic urinary incontinence requiring condom cath now with \nindwelling Foley,\nCAD s/p MI,\nMild dementia\n \nSocial History:\n___\nFamily History:\nNo family history of prostate CA\n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals: 98.3 PO 128/72 L Lying 69 20 99 Ra \nGeneral: A&O2-3 with prompting; fidgeting. \nHEENT: Sclerae anicteric, MMM, oropharynx clear\nNeck: supple, JVP not elevated, no LAD\nLungs: CTAB no wheezes, rales, rhonchi\nCV: RRR, Nl S1, S2, No MRG\nAbdomen: soft, NT/ND bowel sounds present, no rebound tenderness \nor guarding, no organomegaly\nGU: foley in place draining clear yellow urine \nExt: left extremity with 4+ edema through thighs; left leg \nwithout edema, no joint effusions. Both legs warm, well \nperfused, 2+ pulses, no clubbing, cyanosis or edema\nNeuro: CN2-12 intact, no focal deficits\n\nDISCHARGE PHYSICAL EXAM:\nVitals: Tm 99.8, HR 66-88, BP 110-162/61-89, RR ___, 92-97% \nRA; 86% on RA ambulating  \nGEN: no acute distress, awake, alert, oriented to person and \nvaguely to place, not time\nCARDIOVASCULAR: RRR, ___ systolic murmur loudest at upper \nsternal border \nLUNGS: no increased work of breathing, crackles in bases \nbilaterally R>L\nABDOMEN: Soft, non-tender, non-distended \nBACK: R nephrostomy tube in place with dressing clean, dry \nintact, draining serous fluid, no costovertebral angle \ntenderness \nEXTREMITIES: Warm, well perfused, prominent edema of L lower \nextremity from foot to thigh (pulses on L difficult to palpate \nin the setting of edema), trace/1+ pitting edema in RLE, \nsensation to light touch intact in L foot, \ndorsiflexion/plantarflexion strength ___ on left\n \nPertinent Results:\nADMISSION LABS:\n___ 09:20PM BLOOD WBC-11.4* RBC-3.70* Hgb-9.3* Hct-30.2* \nMCV-82 MCH-25.1* MCHC-30.8* RDW-15.1 RDWSD-44.7 Plt ___\n___ 09:20PM BLOOD Neuts-90.6* Lymphs-3.7* Monos-4.0* \nEos-0.5* Baso-0.1 Im ___ AbsNeut-10.32* AbsLymp-0.42* \nAbsMono-0.45 AbsEos-0.06 AbsBaso-0.01\n___ 09:20PM BLOOD ___ PTT-47.7* ___\n___ 09:20PM BLOOD Glucose-113* UreaN-52* Creat-2.3* Na-138 \nK-4.5 Cl-105 HCO3-22 AnGap-16\n___ 09:20PM BLOOD ALT-17 AST-34 LD(LDH)-247 AlkPhos-77 \nTotBili-0.3\n___ 09:20PM BLOOD CK-MB-7 cTropnT-0.70*\n___ 09:20PM BLOOD Albumin-2.8* Calcium-7.8* Phos-2.7 Mg-1.7\n___ 09:20PM BLOOD VitB12-557\n___ 09:20PM BLOOD TSH-1.2\n___ 10:18PM URINE RBC-27* WBC->182* Bacteri-MOD Yeast-NONE \nEpi-0\n___ 10:18PM URINE Blood-MOD Nitrite-POS Protein-100 \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG\n___ 10:18PM URINE Color-Yellow Appear-Hazy Sp ___\n\nMICROBIOLOGY:\nURINE CULTURE (Final ___: \n      KLEBSIELLA PNEUMONIAE.    >100,000 CFU/mL. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_______________________________________________________\n                             KLEBSIELLA PNEUMONIAE\n                             |   \nAMIKACIN--------------     8 S\nAMPICILLIN/SULBACTAM--  =>32 R\nCEFAZOLIN-------------  =>64 R\nCEFEPIME--------------       R\nCEFTAZIDIME-----------     8 I\nCEFTRIAXONE-----------  =>64 R\nCIPROFLOXACIN---------   =>4 R\nGENTAMICIN------------  =>16 R\nMEROPENEM-------------<=0.25 S\nNITROFURANTOIN--------   128 R\nPIPERACILLIN/TAZO-----    16 S\nTOBRAMYCIN------------  =>16 R\nTRIMETHOPRIM/SULFA----  =>16 R\n\n Blood Culture, Routine (Final ___: \n      KLEBSIELLA PNEUMONIAE.    FINAL SENSITIVITIES. \n         Cefepime sensitivity testing performed by Microscan. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             KLEBSIELLA PNEUMONIAE\n                             |   \nAMIKACIN--------------     8 S\nAMPICILLIN/SULBACTAM--  =>32 R\nCEFAZOLIN-------------  =>___ R\nCEFEPIME--------------    16 R\nCEFTAZIDIME-----------     8 I\nCEFTRIAXONE-----------  =>64 R\nCIPROFLOXACIN---------   =>4 R\nGENTAMICIN------------  =>16 R\nMEROPENEM-------------<=0.25 S\nPIPERACILLIN/TAZO-----    16 S\nTOBRAMYCIN------------  =>16 R\nTRIMETHOPRIM/SULFA----  =>16 R\n\nURINE CULTURE (Final ___:  < 10,000 CFU/mL. \n\nIMAGING:\nPercutaneous nephrostomy placement ___:\nFINDINGS: \nMild right-sided hydronephrosis.  Reasonably prompt drainage \nfrom the ureter with no evidence distal obstruction. \nIMPRESSION: \nSuccessful placement of 8.5 ___ nephrostomy on \nthe right.\n\nCXR ___:\nFINDINGS: \nCalcified pleural plaques bilaterally, correlate with prior \nasbestos exposure. Are small right pleural effusion.  Shallow \ninspiration accentuates heart size. Normal pulmonary \nvascularity, no evidence of edema.  Bibasilar opacities, likely \natelectasis superimposed with pleural calcifications.  \nAspiration or pneumonia cannot be excluded.  No pneumothorax.\nIMPRESSION: \nCalcified pleural plaques, correlate with prior asbestos \nexposure. Small right pleural effusion.  No pulmonary edema. \nBibasilar opacities, likely atelectasis, consider aspiration or \npneumonia if appropriate.\n\nTTE ___:\nThe left atrial volume index is severely increased. No atrial \nseptal defect is seen by 2D or color Doppler. The estimated \nright atrial pressure is ___ mmHg. There is moderate symmetric \nleft ventricular hypertrophy with normal cavity size. There is \nmoderate regional left ventricular systolic dysfunction with \nnear akinesis and small aneurysm of the distal third of the \nventricle and hypokinesis of the inferior wall. The remaining \nsegments contract well. Quantitative (biplane) LVEF = 31 %. Left \nventricular cardiac index is depressed (<2.0 L/min/mw2). No \nintraventricular thrombus/mass is seen. Tissue Doppler imaging \nsuggests an increased left ventricular filling pressure \n(PCWP>18mmHg). Right ventricular chamber size is normal with \nhypokinesis of the distal free wall. The aortic root is mildly \ndilated at the sinus level. The aortic valve leaflets are \nseverely thickened/deformed. No masses or vegetations are seen \non the aortic valve, but cannot be excluded as the valve is very \ndeformed. There is severe aortic valve stenosis (valve area <1.0 \ncm2). No aortic regurgitation is seen. The mitral valve leaflets \nare mildly thickened. No mass or vegetation is seen on the \nmitral valve. Trivial mitral regurgitation is seen. No masses or \nvegetations are seen on the tricuspid valve, but cannot be fully \nexcluded due to suboptimal image quality. There is moderate \npulmonary artery systolic hypertension. There is no pericardial \neffusion.\nIMPRESSION: Severe aortic valve stenosis with deformed valve but \nno discrete vegetation. Moderate left ventricular systolic \ndysfunction with regional wall motion abnormalities consistent \nwith multi-vessel CAD. Moderate pulmonary artery systolic \nhypertention. Moderate left ventricular hypertrophy. Mildly \ndilated aorta. Increased PCWP. \n\nINTERMITTENT PERTINENT LABS:\n___ 05:01AM BLOOD CK-MB-5 cTropnT-0.65*\n___ 08:19AM BLOOD CK-MB-2 cTropnT-0.51*\n___ 05:01AM BLOOD calTIBC-163* VitB12-454 Ferritn-157 \nTRF-125*\n___ 05:01AM BLOOD Albumin-2.4* Calcium-7.3* Phos-2.9 Mg-2.0 \nIron-5*\n\nDISCHARGE LABS:\n___ 04:22AM BLOOD WBC-6.4 RBC-3.16* Hgb-8.1* Hct-25.9* \nMCV-82 MCH-25.6* MCHC-31.3* RDW-15.2 RDWSD-45.1 Plt ___\n___ 04:22AM BLOOD Glucose-106* UreaN-28* Creat-1.4* Na-147* \nK-4.3 Cl-111* HCO3-26 AnGap-14\n___ 04:22AM BLOOD Albumin-2.6* Calcium-8.2* Phos-3.5 Mg-1.8\n___ 07:49AM BLOOD ___\n \nBrief Hospital Course:\nMr. ___ is a ___ man with a remote history of prostate \ncancer s/p prostatectomy and LN resection c/b LLE lymphedema, \nrecent h/o bladder cancer, chronic urinary incontinence \nrequiring catheterization now with foley, CAD s/p MI, and mild \ndementia presenting from ___ with ___, right \nhydronephrosis, and ESBL Klebsiella bacteremia/sepsis with \nhospital course c/b NSTEMI, also found to have severe aortic \nstenosis and newly reduced EF (31%).\n\n#Sepsis\n#Klebsiella bacteremia\nUpon admission, patient was intermittently febrile but \nhemodynamically stable with blood and urine cultures from ___ \n___ growing ESBL Klebsiella. Initially, he was continued on \nZosyn, which had been started at ___ for undifferentiated \nGNR bacteremia. However, on ___ he was switched to meropenem \nafter cultures grew a highly resistant strain of Klebsiella. \nBlood and urine cultures from ___ and ___ at ___ were also \npositive for Klebsiella. By ___ he was no longer spiking fevers \nand WBC was normal. A midline was placed for continued IV abx \ntherapy and he was transitioned to ertapenem at discharge. \n\n___\n#R hydrohephrosis s/p nephrostomy placement\nPatient presented to ___ with ___ and Cr elevation to 4.6, \nfound to have R hydronephrosis on imaging (thought to be most \nlikely due to an obstructing blood clot or edema from recent \nbladder tumor resection). He also likely had a simultaneous \nprerenal insult in the setting of sepsis, also contributing to \nhis ___.\nCr improved to 2.7 with IVF at ___. Upon arrival at ___, \nCr was 2.5.  The morning after transfer to ___ a R nephrostomy \ntube was placed by ___ at the recommendation of his urologist at \n___. The day following drain placement, Cr decreased to \n2.3 and then was down to 1.5 on ___ and 1.4 on ___. He had a \nsmall amount of blood in the nephrostomy bag on ___. Per ___, \nintermittent mild hematuria is not uncommon in a nephrostomy. \n\n#CAD/NSTEMI\n#HFrEF (newly diagnosed)\n#Severe aortic stenosis\nOn ___ at ___, patient had an acute episode of chest pain \nwith EKG changes (T wave inversions) and elevated troponins c/f \nNSTEMI. Cardiology at ___ did not feel urgent left heart \ncath was necessary and started a heparin gtt, metoprolol, ASA, \nand atorvastatin. Upon admission to ___, cardiology was \nconsulted and felt demand ischemia (type 2 NSTEMI) was most \nlikely. Given low suspicion for acute plaque rupture, the \nheparin gtt was discontinued.  He had a TTE on ___ which showed \nsevere aortic stenosis, newly reduced EF (31%), and regional \nwall motion abnormalities including a small LV aneurysm. A left \nheart catheterizaiton was deferred on this admission due to \nrecovering ___ but will be considered in the future. He will \nalso undergo a work up for possible TAVR as an outpatient. Due \nto akinetic regions of the LV wall and the presence of a small \naneurysm, he was started on apixaban 2.5mg BID in addition to \nASA.  He did have hypoxia to high ___ on room air on ambulation \nearly on in the admission, received one dose of 40mg furosemide \nPO, and was euvolemic without hypoxia for the rest of the \nadmission.\n\n#Toxic metabolic encephalopathy\nPer notes, patient has mild dementia at baseline. Has had \nintermittent confusion and altered mental status in the setting \nof acute infection and prolonged hospitalization. Mental status \nimproved with treatment of infection. Started sun-downing on \n___ and ___ and was started on quetiapine 25mg QPM starting \n___ with improvement.\n\n#Urothelial carcinoma\n#Prostate cancer\nDistant h/o prostate cancer s/p prostatectomy with LN resection \nc/b LLE lymphedema and recent h/o urothelial carcinoma s/p \nresection in ___ with pathology specimen positive for \nurothelial carcinoma and prostate cancer ___ 8). Urology \nwas consulted and did not see a need for further work-up or \nintervention as an inpatient. A foley was left in place per \nurology recs, and it is recommended that he follow up with his \nurologist at ___ for outpatient management.\n\n#Chronic LLE lymphedema\nStable. No treatment was required.\n\n#L toe pain\nPatient reported new pain in left toes. No changes in sensation \nor strength in L foot on exam and no clear erythema of the skin \nor joints. Thought to be related to his chronic LLE lymphedema.\n\n#L ear pain/fullness\nBuild up of cerumen in L ear canal with no e/o otitis media or \notits externa on exam. Treated with 4 days of carbamide peroxide \ndrops.\n\n#HTN\nAntihypertensive medications held in the setting of sepsis.\n\n#Iron deficiency anemia\nHb 9.3 on admission and stable from early ___. Iron studies \nc/w iron deficiency, likely due to poor nutrition versus blood \nloss. Hb trended daily and no transfusions were required.\n\n#Pleural plaques: \n#Dyspnea:\nExtensive calcified pleural plaque formation obscuring lungs per \nOSH CXR report and again visible on CXR from ___, likely \nchronic possibly from previous asbestos exposure. Patient denied \nrespiratory symptoms at rest but was dyspneic and desaturated to \nthe ___ when ambulating. Symptoms thought to be due to severe \naortic stenosis, HFrEF, and deconditioning. He received one dose \nof 40mg furosemide PO on ___ and subsequently was ambulating \nwith SPO2 >93% on RA.\n\nTRANSITIONAL:\n- Ertapenem to be continued daily through ___. Please remove \nmidline when antibiotic course complete.\n- Patient did have episode of sundowning on ___ with \nconfusion. Please ensure midline catheter is wrapped with sleeve \nto prevent accidental removal.\n- Please taper quetiapine as follows: 25mg QPM on ___ and ___, \n12.5mg on ___ and ___, then stop.\n- f/u with ___ for nephrostogram and eventual nephrostomy removal \nin 6 weeks. ___ will contact facility or patient with the \nappointment information.\n- Nephrostomy Catheter flushing: If there are excessive blood \nclots or debris or thick urine within the connecting tubing, \nthis can also be flushed as needed to clear from the stopcock \ninto the drainage bag.\n- Foley catheter to remain in until patient follows up with \nurology. \n- Please ensure patient gets followup for TAVR workup and \nconsider outpatient left heart catheterization.\n- Pleural plaques seen on chest X-ray. Please consider \noutpatient workup.\n- Please monitor daily weights and consider diuresis if weight \nincreases by >3lb in 2 days or 5lb in 5 days.\n- Please check complete metabolic panel weekly starting ___ \nto ensure stability of renal function.\n- Please start lisinopril 2.5mg daily for ischemic \ncardiomyopathy if renal function is stable on ___.\n- Please consider dermatology followup for left ear skin lesion.\n\n===========\n>30 minutes in patient care and coordination of discharge\n===========\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. lisinopril-hydrochlorothiazide ___ mg oral DAILY \n2. Atorvastatin 80 mg PO QPM \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q8H:PRN Pain - Mild/Fever  \n2.  Apixaban 2.5 mg PO/NG BID  \n3.  Aspirin 81 mg PO DAILY  \n4.  Docusate Sodium 100 mg PO BID  \n5.  FoLIC Acid 1 mg PO DAILY  \n6.  Metoprolol Succinate XL 25 mg PO DAILY  \n7.  QUEtiapine Fumarate 12.5 mg PO QPM  \n8.  QUEtiapine Fumarate 12.5 mg PO QPM:PRN agitation  \n9.  Senna 17.2 mg PO HS  \n10.  Thiamine 100 mg PO DAILY  \n11.  Atorvastatin 80 mg PO QPM  \n12. HELD- lisinopril-hydrochlorothiazide ___ mg oral DAILY  \nThis medication was held. Do not restart \nlisinopril-hydrochlorothiazide until your doctors ___ to do \nso.\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary: Gram negative UTI and bacteremia\nSecondary: Acute kidney injury, Type 2 NSTEMI, severe aortic \nstenosis, left ventricular aneurysm, ischemic cardiomyopathy\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nIt was a pleasure taking care of you at ___. You were admitted \nbecause of an infection in your urine that had spread to your \nblood. You were treated with intravenous antibiotics and this \ninfection improved. You should continue taking the IV antibiotic \nthrough ___.\n\nThe infection may have developed because of an obstruction of \nurine outflow from the right kidney. You had a tube placed on \nyour right side to drain the fluid building up in the right \nkidney. After this drain was placed, your kidney function \nimproved. This drain should stay in place for 6 weeks.\n\nYou also had an echocardiogram (ultrasound of the heart) because \nof the heart attack you had when you were at ___. \nThis test showed that there is severe narrowing of one of the \nheart valves, which may be causing you to feel short of breath \nwhen walking. We would like to you to follow up with cardiology \nfor further evaluation.\n\nPlease seek immediate medical attention if you have chest pain, \nshortness of breath, weight gain, increased swelling in your \nlower extremities, blood in the urine, or fever greater than \n101.\n\nIf you have further questions, please contact your outpatient \nproviders.\n\nSincerely,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
}